14-3-3 Protein, Spinal Fluid
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluation of patients with rapidly progressive dementia to establish the diagnosis of Creutzfeldt-Jakob disease
Immunochemiluminometric Assay (ICMA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
14-3-3 Protein, CSF